These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 12666065

  • 1. Stem cell factor and crescentic glomerulonephritis.
    El Kossi MM, El Nahas AM.
    Am J Kidney Dis; 2003 Apr; 41(4):785-95. PubMed ID: 12666065
    [Abstract] [Full Text] [Related]

  • 2. Role of stem cell factor and mast cells in the progression of chronic glomerulonephritides.
    El-Koraie AF, Baddour NM, Adam AG, El Kashef EH, El Nahas AM.
    Kidney Int; 2001 Jul; 60(1):167-72. PubMed ID: 11422748
    [Abstract] [Full Text] [Related]

  • 3. Mast cells and tubulointerstitial fibrosis in patients with ANCA-associated glomerulonephritis.
    Otsubo S, Nitta K, Uchida K, Yumura W, Nihei H.
    Clin Exp Nephrol; 2003 Mar; 7(1):41-7. PubMed ID: 14586742
    [Abstract] [Full Text] [Related]

  • 4. Glomerular expression of C-C chemokines in different types of human crescentic glomerulonephritis.
    Liu ZH, Chen SF, Zhou H, Chen HP, Li LS.
    Nephrol Dial Transplant; 2003 Aug; 18(8):1526-34. PubMed ID: 12897090
    [Abstract] [Full Text] [Related]

  • 5. Stem cell factor in a rat model of serum nephrotoxic nephritis.
    El Kossi MM, Haylor JL, Johnson TS, El Nahas AM.
    Nephron Exp Nephrol; 2008 Aug; 108(1):e1-e10. PubMed ID: 18087173
    [Abstract] [Full Text] [Related]

  • 6. Role of mast cells, stem cell factor and protease-activated receptor-2 in tubulointerstitial lesions in IgA nephropathy.
    Liu H, Liu F, Peng Y, Liu Y, Li L, Tu X, Cheng M, Xu X, Chen X, Ling G, Sun L.
    Inflamm Res; 2010 Jul; 59(7):551-9. PubMed ID: 20131076
    [Abstract] [Full Text] [Related]

  • 7. Quantitative analysis of the interstitial mast cells in idiopathic mesangiocapillary glomerulonephritis type I.
    Danilewicz M, Wagrowska-Danilewicz M.
    Nefrologia; 2001 Jul; 21(3):253-9. PubMed ID: 11471306
    [Abstract] [Full Text] [Related]

  • 8. Mast cells in rapidly progressive glomerulonephritis.
    Tóth T, Tóth-Jakatics R, Jimi S, Ihara M, Urata H, Takebayashi S.
    J Am Soc Nephrol; 1999 Jul; 10(7):1498-505. PubMed ID: 10405205
    [Abstract] [Full Text] [Related]

  • 9. Myofibroblasts and the progression of crescentic glomerulonephritis.
    Goumenos D, Tsomi K, Iatrou C, Oldroyd S, Sungur A, Papaioannides D, Moustakas G, Ziroyannis P, Mountokalakis T, El Nahas AM.
    Nephrol Dial Transplant; 1998 Jul; 13(7):1652-61. PubMed ID: 9681707
    [Abstract] [Full Text] [Related]

  • 10. The stem cell factor-c-kit system and mast cells in human pancreatic cancer.
    Esposito I, Kleeff J, Bischoff SC, Fischer L, Collecchi P, Iorio M, Bevilacqua G, Büchler MW, Friess H.
    Lab Invest; 2002 Nov; 82(11):1481-92. PubMed ID: 12429808
    [Abstract] [Full Text] [Related]

  • 11. Increased density of interstitial mast cells in amyloid A renal amyloidosis.
    Tóth T, Tóth-Jakatics R, Jimi S, Takebayashi S.
    Mod Pathol; 2000 Sep; 13(9):1020-8. PubMed ID: 11007043
    [Abstract] [Full Text] [Related]

  • 12. Glomerular chemokine expression and the effect of steroid and cyclophosphamide pulse therapy in human crescentic glomerulonephritis.
    Chen S, Liu Z, Chen H, Zhou H, Wang J, Li L.
    Chin Med J (Engl); 2002 Sep; 115(9):1301-7. PubMed ID: 12411099
    [Abstract] [Full Text] [Related]

  • 13. [Relationship between epithelial-immunologic cells transdifferentiation and pseudoepitheliomatous granuloma lesion].
    Jiang DY, Fu XB, Chen W, Sun TZ, Sheng ZY.
    Zhonghua Wai Ke Za Zhi; 2004 Apr 07; 42(7):400-5. PubMed ID: 15144666
    [Abstract] [Full Text] [Related]

  • 14. [The role of smooth muscle alpha-actin in development of renal fibrosis in patients with chronic glomerulonephritis].
    Chebotareva NV, Bobkova IN, Varshavskiĭ VA, Golitsyna EP, Kozlovskaia LV.
    Ter Arkh; 2006 Apr 07; 78(5):17-21. PubMed ID: 16889044
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical analysis of the interstitial mast cells in rebiopsied patients with idiopathic mesangial proliferative glomerulonephritis.
    Danilewicz M, Wagrowska-Danilewicz M.
    Pol J Pathol; 2005 Apr 07; 56(2):63-8. PubMed ID: 16092667
    [Abstract] [Full Text] [Related]

  • 16. Mast cell distribution and activation in chronic pancreatitis.
    Esposito I, Friess H, Kappeler A, Shrikhande S, Kleeff J, Ramesh H, Zimmermann A, Büchler MW.
    Hum Pathol; 2001 Nov 07; 32(11):1174-83. PubMed ID: 11727255
    [Abstract] [Full Text] [Related]

  • 17. Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony-forming cell.
    Agis H, Willheim M, Sperr WR, Wilfing A, Krömer E, Kabrna E, Spanblöchl E, Strobl H, Geissler K, Spittler A, Boltz-Nitulescu G, Majdic O, Lechner K, Valent P.
    J Immunol; 1993 Oct 15; 151(8):4221-7. PubMed ID: 7691941
    [Abstract] [Full Text] [Related]

  • 18. Quantitative analysis of interstitial mast cells in lupus and non-lupus membranous glomerulopathy.
    Danilewicz M, Wagrowska-Danilewicz M.
    Pol J Pathol; 2001 Oct 15; 52(4):211-7. PubMed ID: 11915183
    [Abstract] [Full Text] [Related]

  • 19. Predicting the prognosis of renal dysfunction by renal expression of alpha-smooth muscle actin in children with MPGN type 1.
    Kawasaki Y, Suzuki J, Sakai N, Tanji M, Suzuki H.
    Am J Kidney Dis; 2003 Dec 15; 42(6):1131-8. PubMed ID: 14655183
    [Abstract] [Full Text] [Related]

  • 20. [Phenotypic characteristics of infiltrated inflammatory cells, renal tubular epithelial cells and interstitial cells and their possible roles in the outcome of human drug-associated interstitial nephritis].
    Yang L, Li X, Zheng X.
    Zhonghua Yi Xue Za Zhi; 2001 Jan 25; 81(2):73-7. PubMed ID: 11798853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.